Protease inhibitors and anticonvulsants.
Brooks
J
J
Brigham and Women's Hospital, Boston, MA.
Daily
J
J
Schwamm
L
L
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002220:Carbamazepine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D010634:Phenobarbital / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D010672:Phenytoin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000927:Anticonvulsants; D065607:Cytochrome P-450 Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D007527:Isoenzymes; D002220:Carbamazepine; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D010634:Phenobarbital